ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jul 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
August 2025
Nuclear Technology
Fusion Science and Technology
Latest News
ANS joins others in seeking to discuss SNF/HLW impasse
The American Nuclear Society joined seven other organizations to send a letter to Energy Secretary Christopher Wright on July 8, asking to meet with him to discuss “the restoration of a highly functioning program to meet DOE’s legal responsibility to manage and dispose of the nation’s commercial and legacy defense spent nuclear fuel (SNF) and high-level radioactive waste (HLW).”
George A. Miller, Jr., Nolan E. Hertel, Bernard W. Wehring, John L. Horton
Nuclear Technology | Volume 103 | Number 3 | September 1993 | Pages 320-331
Technical Paper | Radiation Biology and Medicine | doi.org/10.13182/NT93-A34855
Articles are hosted by Taylor and Francis Online.
A computer study of the dose distribution for gadolinium neutron capture therapy is carried out to determine its feasibility. Gadolinium is a potential neutron capture therapy (NCT) agent that produces gamma radiation, conversion electrons, and Auger electrons. The dose distribution from neutrons, neutron-induced gammas, and the reaction products from neutron capture in gadolinium were modeled using the Los Alamos National Laboratory Monte Carlo neutron photon computer code. The results of these calculations are that gadolinium has promise as an NCT agent. Using two parallel opposed epithermal neutron beams for a tumor at an 8.0-cm depth with a gadolinium loading of 100 µg/g, the tumor to peak normal tissue dose was determined to be 1.48.